Physiological assessment of orthostatic intolerance in chronic fatigue syndrome.
Natelson, Benjamin H, Lin, Jin-Mann S, Blate, Michelle et al. · Journal of translational medicine · 2022 · DOI
Quick Summary
This study tested how the bodies of ME/CFS patients respond when they shift from lying down to leaning upright for 10 minutes. Researchers measured heart rate, blood pressure, breathing, and carbon dioxide levels in the blood. They found that 60% of patients showed abnormal responses, with low blood carbon dioxide levels being the most common problem, followed by an excessively fast heartbeat when standing.
Why It Matters
This research identifies a simple, reproducible test that reveals objective physiological abnormalities in ME/CFS patients that would be missed by standard clinical evaluation alone. The finding that hypocapnia is both common and persistent suggests a potential biomarker worthy of further investigation as a therapeutic target.
Observed Findings
60.3% of ME/CFS patients showed at least one abnormality during lean testing, with prevalence slightly decreasing at follow-up visits (51% at visit 1, 50% at visit 2, 45% at visit 3)
Hypocapnia was the most frequent abnormality, more common and more persistent than postural orthostatic tachycardia
Anxiety scores did not differ between patients with and without hypocapnia, suggesting the breathing abnormality is not primarily anxiety-driven
Capnography (CO2 measurement) detected abnormalities that would have been missed by measuring vital signs alone
Inferred Conclusions
The 10-minute lean test with capnography is a useful clinical tool for detecting orthostatic intolerance in ME/CFS patients
Hypocapnia appears to be a characteristic physiological feature of ME/CFS that warrants further investigation as a potential biomarker
The persistence of hypocapnia across multiple years suggests this may represent a stable, underlying physiological abnormality rather than a temporary state
Remaining Questions
What physiological mechanism causes hypocapnia in ME/CFS, and does it directly contribute to symptoms or is it an epiphenomenon?
Would interventions specifically targeting hypocapnia (such as breathing retraining or other therapies) improve patient symptoms and quality of life?
What This Study Does Not Prove
The study does not establish that orthostatic intolerance causes ME/CFS symptoms or explain the underlying mechanisms producing hypocapnia. It does not determine whether correcting these physiological abnormalities would improve patient symptoms, and the lack of a healthy control group prevents definitive assessment of how these findings compare to non-ME/CFS populations.